Christopher M. Reid

1992–2026 年に発表

別表記
Christopher M Reid
236
論文数
23,033
被引用数
81
h 指数
216
i10 指数

被引用数

Christopher M. Reid の年別被引用数1985 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 4 件1997 年: 被引用 2 件1998 年: 被引用 4 件1999 年: 被引用 10 件2000 年: 被引用 7 件2001 年: 被引用 13 件2002 年: 被引用 16 件2003 年: 被引用 48 件2004 年: 被引用 48 件2005 年: 被引用 39 件2006 年: 被引用 65 件2007 年: 被引用 59 件2008 年: 被引用 51 件2009 年: 被引用 57 件2010 年: 被引用 57 件2011 年: 被引用 51 件2012 年: 被引用 62 件2013 年: 被引用 64 件2014 年: 被引用 79 件2015 年: 被引用 82 件2016 年: 被引用 145 件2017 年: 被引用 133 件2018 年: 被引用 158 件2019 年: 被引用 589 件2020 年: 被引用 620 件2021 年: 被引用 736 件2022 年: 被引用 745 件2023 年: 被引用 655 件2024 年: 被引用 1,152 件2025 年: 被引用 643 件2026 年: 被引用 44 件1986〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,104 件、この内訳の 19.6%オーストラリア: 引用元論文 917 件、この内訳の 8.5%イギリス: 引用元論文 849 件、この内訳の 7.9%中国: 引用元論文 777 件、この内訳の 7.2%イタリア: 引用元論文 506 件、この内訳の 4.7%カナダ: 引用元論文 475 件、この内訳の 4.4%ドイツ: 引用元論文 445 件、この内訳の 4.2%オランダ: 引用元論文 309 件、この内訳の 2.9%フランス: 引用元論文 297 件、この内訳の 2.8%スペイン: 引用元論文 270 件、この内訳の 2.5%スイス: 引用元論文 229 件、この内訳の 2.1%スウェーデン: 引用元論文 219 件、この内訳の 2%
0%19.6%その他 31.2%

分野

  • Medicine74.8%
  • Biochemistry, Genetics and Molecular Biology9.9%
  • Neuroscience2.9%
  • Social Sciences2.3%
  • Health Professions2%
  • Psychology1.6%
  • その他6.5%

トピック

  • Blood Pressure and Hypertension Studies5.3%
  • Lipoproteins and Cardiovascular Health2.7%
  • Acute Myocardial Infarction Research2.4%
  • Antiplatelet Therapy and Cardiovascular Diseases2%
  • Heart Failure Treatment and Management1.9%
  • Cardiac Imaging and Diagnostics1.6%
  • その他84.1%

共著者

全論文

検索で開く
  1. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, Kizuku Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, Masunori Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, Christopher R. Palmer, Anushka Patel, Marc Allan Pfeffer, Bertram Pitt, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, Takao Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Zhen‐Yu Zhang, Craig S. Anderson, Colin Baigent, Barry M. Brenner, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi, Johan Sundström, Fiona Turnbull, Giancarlo Viberti, Ji‐Guang Wang, John Chalmers, Koon Teo, Carl J. Pepine, Barry R. Davis - The Lancet 2021 被引用: 1,001

  2. Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2023 被引用: 389

  3. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suzanne Satterfield, Richard H. Grimm, Anne M. Murray - New England Journal of Medicine 2018 被引用: 1,121

  4. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 813

  5. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rury R. Holman, Yutaka Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, Kizuku Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, Masunori Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, Christopher R. Palmer, Anushka Patel, Marc Allan Pfeffer, Bertram Pitt, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, Takao Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Mark Woodward, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Zhen‐Yu Zhang, Craig S. Anderson, Colin Baigent, Barry M. Brenner, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi, Johan Sundström, Fiona Turnbull, Giancarlo Viberti, Ji‐Guang Wang, John Chalmers, Barry R. Davis ほか 2 名 - The Lancet 2021 被引用: 321

  6. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peggy Gao, Rafael Díaz, Eva Lonn - New England Journal of Medicine 2016 被引用: 844

  7. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George K. Dresser, Michel Vallée, Shivinder Jolly, S. P. Chow, Ji‐Guang Wang, Jianjun Mu, Jing Yu, Hong Yuan, Yingqing Feng, Xin Zhang, Jianhong Xie, Ling Lin, Miroslav Souček, J Widimský, Renata Cífková, J. Václavík, Martin Ullrych, Martin Lukáč, Ivan Rychlík, Thomas Guldager Lauridsen, Ilkka Kantola, Jyrki Taurio, Olavi Ukkola, Olivier Ormezzano, Philippe Gosse, Michel Azizi, Pierre‐Yves Courand, Pascal Delsart, Jean Michel Tartiere, Felix Mahfoud, Roland E. Schmieder, Johannes Stegbauer, Philipp Lurz, Michael Koziolek, Christian Ott, Nicole Toursarkissian, Konstantinos Tsioufis, K. Kyfnidis, Athanasios Manolis, Sotirios Patsilinakos, Pantelis Zebekakis, Apostolos Karavidas, Pall Denes, Katalin Bezzegh, Marianna Zsom, László Kovács, Yehonatan Sharabi, Mazen Elias, Ivetta Sukholutsky, Chaim Yosefy, Irina Kenis, Shaul Atar, Massimo Volpe, Muiesan Maria Lorenza, Stefano Taddei, Guıdo Grassı, Franco Veglio, Jung‐Woo Son, Jang‐Young Kim, Joong-Il Park, Chang Hoon Lee, Hae‐Young Lee, Rasa Raugalienė, Jolanta Elena Marcinkeviciene, Roma Kavaliauskiene, Jaap Deinum, Abraham A. Kroon, Bert‐Jan H. van den Born, Andrzej Januszewicz, Andrzej Tykarski ほか 115 名 - The Lancet 2022 被引用: 227

  8. Effect of Aspirin on Disability-free Survival in the Healthy Elderly

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 587

  9. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Journals of Gerontology Series A 2017 被引用: 236

  10. The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival

    著者: , , , , , - Cancer Epidemiology Biomarkers & Prevention 2019 被引用: 183

  11. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline

    著者: , , , , , , , , , , , , , , , , , , - Neurology 2020 被引用: 179

  12. Social isolation, social support and loneliness as predictors of cardiovascular disease incidence and mortality

    著者: , , , , , , , , , , , - BMC Geriatrics 2021 被引用: 155

  13. Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly – eXTension (ASPREE-XT) Observational Study

    著者: , , , , , , , , , , , , , , , - Contemporary Clinical Trials 2023 被引用: 84

  14. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J A Cutler, Richard B Devereaux, Jamie P. Dwyer, R Estacio, Robert Fagard, Keith A.A. Fox, Tomohiro FUKUI, Yutaka Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, K Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, M Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, C. Palmer, Anushka Patel, Marc Allan Pfeffer, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, T Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Z Y Zhang, Craig S. Anderson, Colin Baigent, Brenner Bm, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Bertram Pitt, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi‐Khorshidi, Johan Sundström ほか 3 名 - The Lancet Diabetes & Endocrinology 2022 被引用: 102

  15. Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults

    著者: , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2021 被引用: 100

  16. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay Thakkar, Aravinda Thiagalingam, Harry Klimis - The Lancet 2021 被引用: 150

  17. Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)

    著者: , , , , , , , , , , , , , , , , - BMJ Open 2023 被引用: 67

  18. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hyejung Jung, Gilles R. Dagenais, Salim Yusuf - New England Journal of Medicine 2016 被引用: 618

  19. Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults

    著者: , , , , , , , , , , , , - General Hospital Psychiatry 2017 被引用: 261

  20. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes: a randomized controlled trial

    著者: , , , , , , , , , , , , , , , - Coronary Artery Disease 2020 被引用: 80

  21. Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations

    著者: , , , , , , , , , , , - Cardiovascular Therapeutics 2022 被引用: 46

  22. Platelets in hemostasis and thrombosis: Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectinmediated protein wave of hemostasis

    著者: , , , , , - Journal of Biomedical Research 2015 被引用: 176

  23. Effect of Aspirin on Cancer Incidence and Mortality in Older Adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2020 被引用: 145

  24. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial

    著者: , , , , , , , , , , , , - The Lancet Respiratory Medicine 2020 被引用: 72